Mesenchymal Stem Cells from Wharton´s jelly (Fundación Neumologica Colombiana)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameMesenchymal Stem Cells from Wharton´s jelly (Fundación Neumologica Colombiana)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Stromal cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsScleroderma, SystemicPulmonary FibrosisHypertension, Pulmonary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryColombia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesFundación Neumologica Colombiana

China Registration ClassN/A

Develop Information

Active CompaniesFundación Neumologica Colombiana

Inactive CompaniesN/A

Active IndicationsScleroderma, SystemicPulmonary FibrosisHypertension, Pulmonary

Inactive IndicationsN/A

Other Information

ATC CodeN/A